Company · Healthtech & Bio

Overture Life

www.overture.life ↗ ·Madrid ·Series B

Overture Life is a clinical-stage fertility technology company that automates the IVF and embryology lab through robotics, aiming to make fertility treatment cheaper, more consistent and more widely accessible. Its products include DaVitri (a portable/automated embryology lab for egg vitrification), ICSI.A for automated Piezo-ICSI sperm injection, and m|z metabolomic embryo profiling; its robot performed the fertilizations behind the world's first babies conceived by a sperm-injecting robot (reported by MIT Technology Review in 2023). Founded in Madrid in 2017 by Martin Varsavsky and Santiago Munne, it has raised roughly $57M total, including a $20.6M strategic round in April 2025 led by Overwater Ventures, and has expanded into the U.S. with a CLIA-licensed clinical lab and operations hub in Dallas; R&D remains in Spain.

Founded
2017
Founders
2
News
10
Rounds
4
Investors
5
SectorsFertility Tech, Medical Devices, Robotics, Biotechnology, Femtech Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Profile updated 31 Aug 2026

Founders

Martin Varsavsky
Founder & Chairman
Santiago Munne
Co-Founder & Chief Innovation Officer

Global models

No comparables on record yet.

Investors 5

Investor United States
Investor United States
Khosla Ventures
www.khoslaventures.com ↗
Investor United States
Octopus Ventures
octopusventures.com ↗
Investor United Kingdom
Overwater Ventures
www.overwater.vc ↗
Investor United States

Funding rounds 4

Debt · €20M
The European Investment Bank signed a €20M venture debt loan with Madrid-based Overture Life to fund automation of assisted reproduction pro…
2025-11-04
Series C · $20.6M
Overture Life announced what it described as a $20.6M 'strategic funding round' led by returning investor Overwater Ventures with participat…
2025-04-24
Series B · $15M
Overture Life raised a $15M Series B (reported in Spanish press as about €12.25M) led by London-based Octopus Ventures, with GV making its f…
2021-05-26
Series A · $20M
Overture Life, then usually referred to simply as 'Overture' and led by CEO Martin Varsavsky with co-founder Santiago Munne, closed a $20M S…
2019-07-23

News & media 10

PublishedArticle
2026-06-24 Overture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World's First Automated ICSI into Clinical Use Across Five Leading Global Fertility Centers ↗
Business Wire
2026-06-17 Overture Life Expands Global Footprint with UAE Launch, Partnering with Emitac Healthcare Solutions to Bring Automated IVF to the Gulf ↗
Business Wire
2026-04-14 Overture Life and Spectrun Bio Partner to Bring Automated IVF to Brazil, Advancing Mission to Scale Consistent Embryology Across Latin America ↗
Business Wire
2025-11-25 Overture Life Receives CE Mark for DaVitri Automated Egg Freezing Platform ↗
Femtech Insider
2025-11-05 Overture Life Secures €20M EIB Loan to Advance Its 'Embryology Lab in a Box' ↗
Femtech Insider
2025-10-23 Overture Life Opens First U.S. Clinical Lab and Operations Hub in Dallas as AI-Powered IVF Robotics Headquarters ↗
Business Wire
2025-09-16 Overture Life Launches European Preorder Waitlist for DaVitri, the World's First Microfluidics-Based Automated Vitrification Platform ↗
Business Wire
2025-07-17 Overture Life Signs Agreement With Memorial Hospital Istanbul for World's First Commercial Automated IVF Technology ↗
Business Wire
2025-07-15 Overture Life Appoints Former Butterfly Network Executive Matt Combs as Chief Commercial Officer to Lead Scale-up of IVF Automation Technology as Demand Surges Worldwide ↗
Business Wire
2025-04-25 Overture Life Raises $20.6M to Scale IVF Automation Technology, Secures CLIA License ↗
Femtech Insider
Start typing to search across everything.
↑↓ navigate↵ openesc close